Biote Goodwill and Intangible Assets 2021-2025 | BTMD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biote goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biote goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$230.9B
Boston Scientific (BSX)	$156.3B
Stryker (SYK)	$149.6B
EssilorLuxottica (ESLOY)	$141.3B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.9B
ResMed (RMD)	$40.2B
Agilent Technologies (A)	$35.7B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.6B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.9B
Zimmer Biomet Holdings (ZBH)	$21B
Smith & Nephew SNATS (SNN)	$16.4B
Baxter (BAX)	$12.7B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$8.1B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.2B
Haemonetics (HAE)	$2.6B
Acuren (TIC)	$2.3B
Curaleaf Holdings (CURLF)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B